Xilio Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.17

+0.16 (+1.78%)

As of Aug 14, 10:14 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +444.6% upside

Low Target $27.43

Average Target $49.94

High Target $65.11

Current Price $9.17

Current
$9.17

Target
$49.94

$27.43 $49.94 avg $65.11

Scenario Analysis

Bear Case

$27.43

199.1%

Low target

Base Case

$49.94

+444.6%

Avg target

Bull Case

$65.11

+610.0%

High target

Risk/Reward

3.1x

Highly favorable

Price in Context

52-Week High

$12.74

-28.0% from high

52-Week Low

$6.47

+41.7% from low

Target vs 52W High

$49.94

+292.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%